The Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) tablets and capsules in combination with Venclexta (venetoclax) for adults with chronic lymphocytic leukemia (CLL) or ...
The combination of AstraZeneca's Calquence and AbbVie/Roche's Venclexta has become the first all-oral, fixed-duration regimen for patients with newly-diagnosed chronic lymphocytic leukaemia (CLL) in ...
Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 10:00 AM ESTCompany ParticipantsNadim Ahmed - ...
Creating cultures of loving care is not just the right thing to do for staff and patients, it’s a leadership strategy ...
Q4 2025 Earnings Call February 19, 2026 4:30 PM ESTCompany ParticipantsCaitlin Lowie - Vice President of Corporate Communications ...
cleanfleetreport.co on MSN
Shadows and silence: Ukraine's homegrown long-range drones penetrate Russian defenses, reshaping the conflict
The war in Ukraine has lasted longer than most individuals have anticipated and each night there is a twist to it and it ...
Learn why the herbal supplement valerian may not be as safe as you think, and what to watch for if you try it.
A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, and key dietary tweaks—plus insights on benefits, risks, and mechanisms.
Many of the claims made by supply-siders have been disproven over the years Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results